Latest News
September 25, 1997 Meeting of The Science Advisory Board's Carcinogen Identification Committee (CIC): 5-Chloro-o-Toluidine And Its Strong Acid Salts; 2,4,5-Trimethylaniline And Its Strong Acid Salts; Quinoline And Its Strong Acid Salts
Notice of intent to list 18 chemicals by the authoritative bodies or "formally required" mechanisms: 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 15, C.I. Direct Blue 218, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, Nitrobenzene, Estropipate, Ganciclovir sodium, Amiodarone hydrochloride, Atenolol, Ethionamide, Goserelin acetate, Leuprolide acetate, Paclitaxel, Quazepam, Trimetrexate glucuronate
OEHHA has prepared draft hazard identification documents for the three chemicals and announces the availability of the documents for public comment:5-chloro-o-toluidine and its hydrochloride; 2,4,5-trimethylaniline and its hydrochloride; and quinoline.
Availability of the Procedure for Prioritizing Candidate Chemicals for Consideration Under Proposition 65 by the "State's Qualified Experts"
Availability of the Procedure for Prioritizing Candidate Chemicals for Consideration Under Proposition 65 by the "State's Qualified Experts"
Chemicals listed as known to the State to cause reproductive toxicity by the State's Qualified Experts: Arsenic (inorganic oxides) and Cadmium
Health Risk Assessment of Malathion Coproducts in Malathion-Bait Used for Agricultural Pest Eradication in Urban Areas
Supplemental to: Health Risk Assessment of Aerial Application of Mal
Nine chemicals listed pursuant to the administrative mechanisms for listing based upon either (1) a formal identification by an authoritative body that the chemical is a carcinogen or a reproductive toxicant; or, (2) a formal requirement by a state or federal agency that the chemical be identified or labeled as causing cancer or reproductive toxicity.
Details of the basis for rulemaking (Final Statement) for Lead as a Toxic Air Contaminant.
Revision of notice of chemicals under consideration for possible listing via administrative mechanisms: withdrawal of Premarin (CAS No. 12126-59-9) from consideration.